Science Current Events | Science News | Brightsurf.com
 
Email a Friend Send to a friend
Printer Friendly Print Ume'å scientist publishes new findings about origin of plague bacterium

Ume'å scientist publishes new findings about origin of plague bacterium

April 29, 2002

A team including researchers at the Total Defense Research Institute, NBC Defense, in Ume'å, Sweden, and the Department of Molecular Biology, Ume'å University, are publishing in this week's issue of Science new findings that show that the protein Ymt is of crucial importance for the capacity of the plague bacterium to survive and spread the plague via flea vectors. Professor Ãke Forsberg and visiting researcher Dr. Peter Cherepanov are studying the properties that enable the plague bacterium Yersinia pestis to cause life-threatening infections in animals and humans. Increased knowledge of the mechanisms that Y. pestis exploits to conquer the body's immune defense can make it possible to develop new methods of treatment for serious infectious diseases.

Historically, the plague is one of our most feared infectious diseases. During the most wide-spread epidemic in the middle ages, also known as the Black Death, more than 25% of the European population died. Today the disease is not very common, with some 2,000 cases per year. The plague occurs primarily in Africa and Asia, but there are also a few cases in North America every year.

The bacteria are normally spread by fleas, first of all to rodents. Humans can also be infected by fleas. When the disease reaches the lungs of a human, the infection can be spread through the air to other people. The onset of the disease is rapid, with a high temperature and a headache. There is often an enlargement of the lymph glands located near the back of the jaw, which explains why it is also called the bubonic plague. Untreated, the infection quickly reaches the blood, leading to general blood poisoning. Mortality for untreated bubonic plague is over 50%. If the infection is spread by the air to the lungs, the course of the disease is even more rapid, and mortality for untreated lung plague is virtually 100%. The high rate of mortality, together with the rapid progression of the disease, places plague bacteria among those considered for use as a biological weapon.

Y. pestis is very closely related to another bacterium called Y. pseudotuberculosis. The plague bacterium evolved from Y. pseudotuberculosis as recently as 1,500 to 2,000 years ago. Y. pseudotuberculosis leads to a relatively mild stomach infection in humans.

The key to the capacity of the plague bacterium to cause fatal infections in humans lies in the differences between the two species of bacteria. The plague bacterium has two movable genetic elements, plasmids, that Y. pseudotuberculosis lacks. On one of these plasmids the research team has identified a gene that codes for a previously described "mouse toxin" that is seen as a major part of the explanation for the high potency of the plague bacterium in causing disease.

The researchers have now shown that the gene, Ymt, is not at all involved in the infection of animals but instead is absolutely crucial to the ability of the bacterium to survive in fleas and thereby to spread the disease further. The ability to spread the disease via fleas represents a decisive step in the development of the plague bacterium. Thus, this ability arose in connection with the acquisition of the plasmid that hosts the Ymt gene.

The Ume'å scientists arrived at these findings in collaboration with researchers from the Rocky Mountain Laboratories, NIH, Hamilton, and the University of Michigan Medical School, Ann Arbor, Michigan.

Vetenskapsrådet (The Swedish Research Council)




Related Tuberculosis Current Events and Tuberculosis News Articles Tuberculosis Current Events and Tuberculosis News RSS Tuberculosis Current Events and Tuberculosis News RSS
Researchers identify new leprosy bacterium
A new species of bacterium that causes leprosy has been identified through intensive genetic analysis of a pair of lethal infections, a research team reports in the December issue of the American Journal of Clinical Pathology.

Stopping germs from ganging up on humans
Keeping germs from cooperating can delay the evolution of drug resistance more effectively than killing germs one by one with traditional drugs such as antibiotics, according to new research from The University of Arizona in Tucson.

First trachea transplant without immunosuppression
After 4 years of going from consultation to consultation, Claudia Castillo finally found a solution to her respiratory problems. The young Colombian woman suffered from a cough that took a long time to be diagnosed as tuberculosis.

Proteomics Study Yields Clues As To How Tuberculosis Might Be Thwarting The Immune System
A link between the immune system and the self-cleaning system by which biological cells rid themselves of obsolete or toxic parts may one day yield new weapons in the fight against tuberculosis and other deadly infectious diseases.

XDR-TB: Deadlier and more mysterious than ever
New research has found that XDR-TB is increasingly common and more deadly than previously known. Extensively drug-resistant tuberculosis (XDR-TB) is a growing public health threat that is only just beginning to be understood by medical and public health officials.

Tibotec presents interim findings for TMC435, an investigational genotype 1 hepatitis C treatment
New clinical data show antiviral activity of TMC435, an investigational protease inhibitor (PI) being developed by Tibotec BVBA for the treatment of chronic hepatitis C virus (HCV) infection.

Parasites that live inside cells use loophole to thwart immune system
St. Jude Children's Research Hospital scientists have discovered a mechanism by which intracellular pathogens can shut down one of the body's key chemical weapons against them: nitric oxide.

Persistent bacterial infection exploits killing machinery of immune cells
A new study reveals an important and newly discovered pathway used by disease-causing bacteria to evade the host immune system and survive and grow within the very cells meant to destroy them. This discovery may lead to new treatments and vaccines for tuberculosis (TB) and certain other chronic bacterial and parasitic infections.

Health Care Barriers for Undocumented Immigrants: Raising Tuberculosis Risk?
A new study raises the question, do barriers to health care for undocumented immigrants increase the public health risk of tuberculosis? The study, published in the November 15, 2008 issue of Clinical Infectious Diseases and now available online, suggests that undocumented immigrants with tuberculosis have symptoms longer before seeking care than documented immigrants or U.S.-born patients, resulting in more severe symptoms and more opportunities for transmission.

UCLA develops safer, more effective TB vaccine for HIV-positive people
UCLA scientists engineered a new tuberculosis (TB) vaccine specifically designed for HIV-positive people that was shown to be safer and more potent than the current TB vaccine in preclinical trials.
More Tuberculosis Current Events and Tuberculosis News Articles


The Bioarchaeology of Tuberculosis: A Global View on a Reemerging Disease
by CHARLOTTE ROBERTS, JANE BUIKSTRA

Though apparently in decline during the first half of the 20th century, tuberculosis has reawakened in both developed and developing countries, particularly among susceptible populations with immunodeficiency disorders....



The Forgotten Plague: How the Battle Against Tuberculosis Was Won - And Lost
by Frank Ryan

Tuberculosis has claimed more than a billion lives worldwide. In this acclaimed book, Dr. Frank Ryan tells the remarkable story of the dedicated doctors, chemists, and bacteriologists who halted the course of this ferocious disease--until the "old enemy" found in AIDS a deadly ally to form a drug-resistant synergy. 8 pages of...

Clinician's Guide to Tuberculosis (Clinician's Guide to Tuberculosis (Iseman))
by Michael D. Iseman

Written by an eminent tuberculosis specialist from a premier medical institution, this volume is a practical clinical reference on tuberculosis. The major focus is on bedside care, including diagnosis, treatment, and patient management. The author clearly and concisely explains which treatments are most effective and addresses the problems of managing HIV-positive patients and drug-resistant...



The White Plague: Tuberculosis, Man, and Society
by Rene J. Dubos



Tuberculosis (TUBERCULOSIS ( ROM))

New York Univ., NY. Summarizes the current advances in tuberculosis and discusses the pathology and pathogenesis of the disease. Also covers complications and treatment options. Chapters include history and epidemiology, genomics and microbiology, host response, therapy, and prevention and control. Previous edition: c1996. DNLM:...

Tuberculosis (Deadly Diseases and Epidemics)
by Kim Renee Finer, I. Edward Alcamo

Experts in the field of microbiology tell the great "detective stories" of how some of the world's best-known deadly disease-causing microbes were first isolated, identified, and studied. Readers learn how these deadly viruses and bacteria cause disease and what steps have been taken to eradicate them. Tuberculosis killed one out of every seven people living in the United States and Europe in the...

Diagnostic Standards and Classification of Tuberculosis -
by National Tuberculosis and Respiratory Disease Association -



Captain of Death: The Story of Tuberculosis
by Thomas M. Daniel

The dramatic story of tuberculosis is told here in a straightforward and accessible style. It presents the stories of persons connected with the disease, either as victims, or as those who made contributions to our knowledge of it; in addition to these personal accounts, the book unfolds the history and explains the pathogenesis of TB. The re-emergence of tuberculosis as a major American public...



Tuberculosis (Twenty-First Century Medical Library)
by Diane Yancey

One of the deadliest diseases healthcare workers fight today, tuberculosis (often called TB) infects the lungs of one-third of the world's population and kills about 2 million people a year. While scientific breakthroughs brought this bacterial disease under control during the 1960s to the 1980s, it was never completely eliminated. In the early 1990s, TB came back as a serious global threat. Not...



Tuberculosis and Nontuberculosis Mycobacterial Infections
by David Schlossberg

The Definitive Text on Tuberculosis Infections for More Than Two Decades!. . This trusted resource provides infectious disease specialists with the most comprehensive coverage found anywhere of the varied manifestations of tuberculin diseases and the clinical options available to physicians for treating them. The new edition has been updated to reflect state-of-the-art changes in the direction...

© 2008 BrightSurf.com